Vivo Ventures V, Llc - Net Worth and Insider Trading
Vivo Ventures V, Llc Net Worth
The estimated net worth of Vivo Ventures V, Llc is at least $942,335 dollars as of 2024-08-25. Vivo Ventures V, Llc is the 10% Owner of Sagent Pharmaceuticals Inc and owns about 41,980 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $913,485. Vivo Ventures V, Llc is also the 10% Owner of MEI Pharma Inc and owns about 9,188 shares of MEI Pharma Inc (MEIP) stock worth over $28,850. Details can be seen in Vivo Ventures V, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vivo Ventures V, Llc has not made any transactions after 2015-11-09 and currently still holds the listed stock(s).
Transaction Summary of Vivo Ventures V, Llc
Vivo Ventures V, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures V, Llc owns 4 companies in total, including Soleno Therapeutics Inc (SLNO) , Sagent Pharmaceuticals Inc (SGNT) , and MEI Pharma Inc (MEIP) among others .
Click here to see the complete history of Vivo Ventures V, Llc’s form 4 insider trades.
Insider Ownership Summary of Vivo Ventures V, Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SLNO | Soleno Therapeutics Inc | 2015-08-12 | 10 percent owner |
SGNT | Sagent Pharmaceuticals Inc | 2016-08-29 | 10 percent owner |
MEIP | MEI Pharma Inc | 2015-11-09 | 10 percent owner |
![]() | ![]() | 2007-05-10 | 10 percent owner |
Vivo Ventures V, Llc Latest Holdings Summary
Vivo Ventures V, Llc currently owns a total of 2 stocks. Among these stocks, Vivo Ventures V, Llc owns 41,980 shares of Sagent Pharmaceuticals Inc (SGNT) as of September 16, 2013, with a value of $913,485 and a weighting of 96.94%. Vivo Ventures V, Llc also owns 9,188 shares of MEI Pharma Inc (MEIP) as of November 9, 2015, with a value of $28,850 and a weighting of 3.06%.
Latest Holdings of Vivo Ventures V, Llc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGNT | Sagent Pharmaceuticals Inc | 2013-09-16 | 41,980 | 21.76 | 913,485 |
MEIP | MEI Pharma Inc | 2015-11-09 | 9,188 | 3.14 | 28,850 |
Holding Weightings of Vivo Ventures V, Llc
Vivo Ventures V, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivo Ventures V, Llc has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 539,017 shares on September 16, 2013, which brought Vivo Ventures V, Llc around $11 Million.
According to the SEC Form 4 filings, Vivo Ventures V, Llc has made a total of 0 transactions in MEI Pharma Inc (MEIP) over the past 5 years. The most-recent trade in MEI Pharma Inc is the sale of 1,135 shares on November 9, 2015, which brought Vivo Ventures V, Llc around $41,755.
Insider Trading History of Vivo Ventures V, Llc
- 1
Vivo Ventures V, Llc Trading Performance
Vivo Ventures V, Llc Ownership Network
Ownership Network List of Vivo Ventures V, Llc
Ownership Network Relation of Vivo Ventures V, Llc
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Vivo Ventures V, Llc Owned Company Details
What does Soleno Therapeutics Inc do?
Who are the key executives at Soleno Therapeutics Inc?
Vivo Ventures V, Llc is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include Chief Financial Officer James H Mackaness , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .
Soleno Therapeutics Inc (SLNO) Insider Trades Summary
Over the past 18 months, Vivo Ventures V, Llc made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 342,736 shares made by Bhatnagar Anish , a net sale of 65,201 shares made by Kristen Yen , and a net sale of 33,677 shares made by Patricia C Hirano .
In summary, during the past 3 months, insiders sold 195,096 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 195,096 shares. During the past 18 months, 1,614,953 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 404,866 shares.
Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Soleno Therapeutics Inc Insider Transactions
Vivo Ventures V, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Vivo Ventures V, Llc. You might contact Vivo Ventures V, Llc via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.